GREENPHYTO PTE LTD – Trademark Portfolio
Entity Type: 24
GREENPHYTO PTE LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 7 (Machinery) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GREENPHYTO.
13 TUKANG INNOVATION DRIVE,
GREENPHYTO INNOVATION CENTRE SINGAPORE 619677
Showing of trademarks Trademarks
Trademark Classifications
GREENPHYTO PTE LTD's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Machines and machine tools; motors and engines; machine coupling and transmission components
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does GREENPHYTO PTE LTD have?
GREENPHYTO PTE LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does GREENPHYTO PTE LTD file in?
GREENPHYTO PTE LTD files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 7 (Machinery), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). Class 35 covers advertising; business management; business administration; office functions.
What are GREENPHYTO PTE LTD's most well-known trademarks?
GREENPHYTO PTE LTD's registered trademark portfolio includes well-known marks such as GREENPHYTO. These are among 1 currently registered trademark in the portfolio.
What is GREENPHYTO PTE LTD's trademark registration success rate?
GREENPHYTO PTE LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.